Highly active antiretroviral treatment against STLV-1 infection combining reverse transcriptase and HDAC inhibitors

MLA

Franck Mortreux, et al. Highly Active Antiretroviral Treatment against STLV-1 Infection Combining Reverse Transcriptase and HDAC Inhibitors. Nov. 2010. EBSCOhost, https://doi.org/10.1182/blood-2010-02-270751⟩.

APA

Franck Mortreux, Philippe V. Afonso, Antoine Moriceau, Antoine Gessain, Frederic Toulza, Charles R. M. Bangham, Yves Plumelle, Eric Wattel, Mourad Mekaouche, Renaud Mahieux, Jérôme Estaquier, Olivier Hermine, & Guy Dubreuil. (2010). Highly active antiretroviral treatment against STLV-1 infection combining reverse transcriptase and HDAC inhibitors. https://doi.org/10.1182/blood-2010-02-270751⟩

Chicago

Franck Mortreux, Philippe V. Afonso, Antoine Moriceau, Antoine Gessain, Frederic Toulza, Charles R. M. Bangham, Yves Plumelle, et al. 2010. “Highly Active Antiretroviral Treatment against STLV-1 Infection Combining Reverse Transcriptase and HDAC Inhibitors,” November. doi:10.1182/blood-2010-02-270751⟩.